Literature DB >> 19496610

Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide--relevance to N-terminally truncated forms.

Simon C Drew1, Colin L Masters, Kevin J Barnham.   

Abstract

Copper interactions with the beta-amyloid peptide (Abeta) are believed to play a role in Alzheimer's disease (AD), in particular due to production of reactive oxygen species and Cu(2+)-mediated oligomerization. To understand the role that copper might play in these processes, a detailed knowledge of the fundamental Cu(2+)/Abeta interactions is essential. To date, the identity of the oxygen ligand(s) involved in Cu(2+) coordination by Abeta has remained unclear. Here, we have used site-specific (13)C and (15)N labeling in conjunction with hyperfine sublevel correlation (HYSCORE) spectroscopy to unambiguously identify the carbonyl of Alanine-2 as an oxygen ligand in one of the pH-dependent Cu(2+) coordination modes of Abeta. Polarization of the carbonyl moiety by Cu(2+) could promote amide hydrolysis and cleavage of the peptide bond between Ala2 and Glu3, providing a chemical mechanism for the generation of truncated Abeta 3-40/42 species found in AD plaques.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19496610     DOI: 10.1021/ja903669a

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  29 in total

Review 1.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  In silico strategies for the selection of chelating compounds with potential application in metal-promoted neurodegenerative diseases.

Authors:  Cristina Rodríguez-Rodríguez; Albert Rimola; Jorge Alí-Torres; Mariona Sodupe; Pilar González-Duarte
Journal:  J Comput Aided Mol Des       Date:  2011-01       Impact factor: 3.686

3.  Calorimetric investigation of copper(II) binding to Aβ peptides: thermodynamics of coordination plasticity.

Authors:  Cristina Sacco; Rachel A Skowronsky; Sunitha Gade; John M Kenney; Anne M Spuches
Journal:  J Biol Inorg Chem       Date:  2012-01-22       Impact factor: 3.358

4.  Substantial contribution of the two imidazole rings of the His13-His14 dyad to Cu(II) binding in amyloid-β(1-16) at physiological pH and its significance.

Authors:  Byong-kyu Shin; Sunil Saxena
Journal:  J Phys Chem A       Date:  2011-04-14       Impact factor: 2.781

Review 5.  Misfolded proteins in Alzheimer's disease and type II diabetes.

Authors:  Alaina S DeToma; Samer Salamekh; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Chem Soc Rev       Date:  2011-08-04       Impact factor: 54.564

6.  Nanoprobing of the effect of Cu(2+) cations on misfolding, interaction and aggregation of amyloid β peptide.

Authors:  Zhengjian Lv; Margaret M Condron; David B Teplow; Yuri L Lyubchenko
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-11       Impact factor: 4.147

7.  Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's β by solid-state NMR spectroscopy.

Authors:  Sudhakar Parthasarathy; Fei Long; Yifat Miller; Yiling Xiao; Dan McElheny; Kent Thurber; Buyong Ma; Ruth Nussinov; Yoshitaka Ishii
Journal:  J Am Chem Soc       Date:  2011-02-22       Impact factor: 15.419

Review 8.  Alzheimer's disease & metals: therapeutic opportunities.

Authors:  Vijaya B Kenche; Kevin J Barnham
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 9.  Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.

Authors:  Johant Lakey-Beitia; Andrea M Burillo; Giovanni La Penna; Muralidhar L Hegde; K S Rao
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.

Authors:  Sudhakar Parthasarathy; Brian Yoo; Dan McElheny; William Tay; Yoshitaka Ishii
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.